These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16951543)

  • 1. Regulation of NFAT activation: a potential therapeutic target for immunosuppression.
    Lee M; Park J
    Mol Cells; 2006 Aug; 22(1):1-7. PubMed ID: 16951543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.
    Aramburu J; Yaffe MB; López-Rodríguez C; Cantley LC; Hogan PG; Rao A
    Science; 1999 Sep; 285(5436):2129-33. PubMed ID: 10497131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of the VIVIT Peptide to Human Glioma Cells to Interfere with Calcineurin-NFAT Signaling.
    Ellert-Miklaszewska A; Szymczyk A; Poleszak K; Kaminska B
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders.
    Yu H; van Berkel TJ; Biessen EA
    Cardiovasc Drug Rev; 2007; 25(2):175-87. PubMed ID: 17614939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of calcineurin-NFAT signaling by the pyrazolopyrimidine compound NCI3.
    Sieber M; Karanik M; Brandt C; Blex C; Podtschaske M; Erdmann F; Rost R; Serfling E; Liebscher J; Pätzel M; Radbruch A; Fischer G; Baumgrass R
    Eur J Immunol; 2007 Sep; 37(9):2617-26. PubMed ID: 17694572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity.
    Mulero MC; Aubareda A; Orzáez M; Messeguer J; Serrano-Candelas E; Martínez-Hoyer S; Messeguer A; Pérez-Payá E; Pérez-Riba M
    J Biol Chem; 2009 Apr; 284(14):9394-401. PubMed ID: 19189965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying New Substrates and Functions for an Old Enzyme: Calcineurin.
    Roy J; Cyert MS
    Cold Spring Harb Perspect Biol; 2020 Mar; 12(3):. PubMed ID: 31308145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the calcineurin/NFAT pathway.
    Martínez-Martínez S; Redondo JM
    Curr Med Chem; 2004 Apr; 11(8):997-1007. PubMed ID: 15078162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II activates the calcineurin/NFAT signaling pathway and induces cyclooxygenase-2 expression in rat endometrial stromal cells.
    Abraham F; Sacerdoti F; De León R; Gentile T; Canellada A
    PLoS One; 2012; 7(5):e37750. PubMed ID: 22662209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The calcineurin/NFAT signaling pathway: a novel therapeutic target in leukemia and solid tumors.
    Medyouf H; Ghysdael J
    Cell Cycle; 2008 Feb; 7(3):297-303. PubMed ID: 18235236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds.
    Trevillyan JM; Chiou XG; Chen YW; Ballaron SJ; Sheets MP; Smith ML; Wiedeman PE; Warrior U; Wilkins J; Gubbins EJ; Gagne GD; Fagerland J; Carter GW; Luly JR; Mollison KW; Djuric SW
    J Biol Chem; 2001 Dec; 276(51):48118-26. PubMed ID: 11592964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation.
    Lee MY; Garvey SM; Ripley ML; Wamhoff BR
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2665-75. PubMed ID: 21903947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT.
    Aramburu J; Garcia-Cózar F; Raghavan A; Okamura H; Rao A; Hogan PG
    Mol Cell; 1998 Apr; 1(5):627-37. PubMed ID: 9660947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin.
    Wang L; Cheng N; Wang P; Li J; Jia A; Li W; Zhang N; Yin Y; Tong L; Wei Q; Liu G; Li Z; Luo J
    J Biol Chem; 2020 Feb; 295(9):2760-2770. PubMed ID: 31941790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin/NFAT signaling in primary pancreatic islet β-cells.
    Demozay D; Tsunekawa S; Briaud I; Shah R; Rhodes CJ
    Diabetes; 2011 Nov; 60(11):2892-902. PubMed ID: 21940781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway.
    Min LJ; Mogi M; Tamura K; Iwanami J; Sakata A; Fujita T; Tsukuda K; Jing F; Iwai M; Horiuchi M
    J Mol Cell Cardiol; 2009 Dec; 47(6):798-809. PubMed ID: 19769983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcineurin inhibitors and calcineurin-NFAT system].
    Amasaki Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(5):249-61. PubMed ID: 21048386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitor.
    Yu H; Bot I; Sliedregt K; Xu X; Bot M; van Heiningen SH; van der Marel GA; Bennett MR; Overkleeft H; van Berkel TJ; Biessen EA
    Circ Res; 2012 Jan; 110(2):200-10. PubMed ID: 22116820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.